Bibliografi

American Society for Aesthetic Plastic Surgery. Quick Facts: Highlights of the ASAPS 2007 Statistics on Cosmetic Surgery. Available at: http://www.surgery.org. Accessed March 17, 2008
Amin SP, Phelps RG, Goldberg DJ. (2006) Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg; 32: 1467-72.
Angus JE, Affleck AG, leach IH, Millard LG. (2006) Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel. Br J Dermatol. Nov;155(5):1077-8.
Balazs EA, Bland PA, Denlinger JL et al. (1991) Matrix engineering. Blood Coagul Fibrinolysis Feb;2(1):173-8.
Balazs EA, Denlinger JL (1989) Clinical uses of hyaluronan. Ciba Found Symp;143:265-75; discussion 275-80, 281-5.
Balazs EA, Leshchiner E, Larsen N, Band P. (1995) Hyaluronan biomaterials: medical applications. Wise DL, editor. Handbook of biomaterials and applications. New York: Marcel Dekker Inc: 1693-1715.
Balazs EA, Leshchiner EA. (1989) Hyaluronan its crosslinked derivative – hylan – and their medical applications. Inagaki H, Phillips GO, editors. Cellulosics utilization: research and rewards in cellulosics. Proceedings of Nisshinbo International Conference in Cellulosics Utilization in the Near Future;. New York: Elsevier Applied Science; 233-241.
Balazs EA. (1991) Medical application of hyaluronan and its derivates. Gebelein CG, Cheng F, Yang V, editors. Cosmetic and pharmaceutical application of polymers. London. Plenum Press;.293-310.
Bardazzi F, Ruffato A, Antonucci A, Balestri R, Tabanelli M. (2007) Cutaneous granulomatous reaction to injectable hyaluronic acid gel: another case. J Dermatolog Treat 18(1):59-62
Baumann L. (2004) Hyaluronic Acid in Fillers and Creams. Skin & Aging ISSN: 1096-0120 Vol 12 Issue 1 Jan: 86-88
Baumann L. (2006) Collagen-containing fillers: alone and in combination. Clin Plast Surg Oct;33(4):587-96
Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PS. (2007) Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Surg Dec;33 Suppl 2:S128-35
Bellman B. (2005) Immediate and delayed hypersensitivity reactions Restylane. Aesthetic Surgery Journal Volume 25, Issue 5, Sept-Oct, pages 489-491.
Bergeret-Galley C, Latouche X, Illouz YG. (2001) The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthetic Plast Surg Jul-Aug;25(4):249-55.
Bosniak S, Cantisano-Zilkha M, Purewal BK, Zdinak LA. (2006) Combination therapies in oculofacial rejuvenation. Orbit Dec;25(4):319-26.
Bosniak S, Cantisono-Zilkha M. (2001) Restylane and Perlane: A six year clinical experience. Operative Techniques in Oculoplastic, Orbital and Reconstructive Surgery Vol.4, No:2. 89-93.
Butterwick KJ, Nootheti PK, Hsu JW, et al. Autologous fat transfer: an in-depth look at varying concepts and techniques. Facial Plast Surg Clin North Am 15(1):99-111 (2007 Feb)
Carruthers A, Carruthers J. (2007) Non-animal-based hyaluronic acid fillers: scientific and technical considerations. Plast Reconstr Surg Nov;120(6 Suppl):33S-40S
Carruthers J, Klein W, Carruthers et al. (2005) Safety and Efficacy of Hyaluronic acid for Mouth Corners. Dermatol Surg 31:279-280.
Carruthers JD, Glogau RG, Blitzer A. (2008) Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies–consensus recommendations. Plast Reconstr Surg May;121(5 Suppl):5S-30S; quiz 31S-36S
Centers for Disease Control prevention (CDC) Outbreak of mesotherapy assiciated skin reactions—District of Columbia-area. January-February 2005. MMWR Morb Mortal Wkly Rep 2005; 54: 1127-30.
DeLorenz C, Weinberg M, Solish N, Swift A. (2006) Multicenter study of the efficacy and safety of subcutaneous non-animal-stabilized hyaluronic acid in aesthetic facial contouring: interim report. Dermatol Surg Feb;32(2):205-11.
Duranti F, Salti G, Bovani B, Calandra M, Rosati ML (1998) Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg Dec;24(12):1317-25.
Erstellt von hc / F [Clinical study – [crosslinked Hyaluronic acid 2,3% i.d.]] Seite 24 von 26
Erstellt von hc / F [Clinical study – [crosslinked Hyaluronic acid 2,3% i.d.]] Seite 25von 26
Erstellt von hc / F [Clinical study – [crosslinked Hyaluronic acid 2,3% i.d.]] Seite 26 von 26
Erstellt von hc / F [Clinical study – [crosslinked Hyaluronic acid 2,3% i.d.]] Seite 27 von 26
Fernandez-Acenero J, Zamora E, Borbujo J. (2001) Granulomatous Foreign Body Reaction Against Hyaluronic Acid: Report of a Case after Lip Augmentaion. Dermatol Surg 29:1225-1226.
Fraser J.R.E., Laurent T.C., Engström-Laurent A. and Laurent U.G.B. (1984), Elimination of Hyaluronic Acid from the Blood Stream in the Human. Clinical and Experimental Pharmacology and Physiology, 11: 17-25.
Fraser JR, Laurent TC, Pertoft H, and Baxter E. (1981) Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J. November 15; 200(2): 415–424.
Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. (2002) Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg Jun;28(6):491-4.
Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. (2002) Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg Jun;28(6):491-4.
Goldman MP, Alster TS, Weiss R. (2007) A randomized trial to determine the influence of laser therapy, monopolar radiofrequency treatment, and intense pulsed light therapy administered immediately after hyaluronic acid gel implantation. Dermatol Surg May;33(5):535-42.
Hamilton RG, Strobos J, Adkinson NF Jr. (2007) Immunogenicity studies of cosmetically administered nonanimal-stabilized hyaluronic ascid particles. Dermatol Surg Dec;33 Suppl 2:S176-85.
In Vivo Stimulation of De Novo Collagen Production Caused by Cross-Linked Hyaluronic Acid Dermal Filler Injections in Photodamaged Human Skin Wang F, Garza LA, Kang S, et al Arch Dermatol. 2007;143:155-163
Klein AW, Fagien S. (2007) Hyaluronic acid fillers and botulinum toxin type a: rationale for their individual and combined use for injectable facial rejuvenation. Plast Reconstr Surg 2007 Nov;120(6 Suppl):81S-88S
Landau M. (2006) Combination of chemical peelings with botulinum toxin injections and dermal fillers. J Cosmey Dermatol Jun;5(2):121-6
Lowe NJ, Grover R. Injectable hyaluronic acid implant for malar and mental enhancement. Dermatol Surg 32(7):881-5 (2006 Jul)
Lowe NJ, Maxwell CA, Patnaik R. (2007) Adverse reactions to dermal fillers: review. Dermatol Surg Nov;31(11 Pt 2):1616-25
Lupo MP, Smith SR, Thomas JA, Murphy DK, Beddingfield FC 3 rd . (2008) Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plastic Reconstr Surg Jan;121(1):289-97
Lupo MP. Hyaluronic acid fillers in facial rejuvenation. Semin Cutan Med Surg 25(3):122-6 (2006 Sep)
Lupton JR, Alster TS. (2000) Cutaneous hypersensitivity reaction to injectable hyaluronic gel. Dermatol Surg 26:135-7
Moers-Carpi M, Vogt S, Santos BM et al. (2007) A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg 33 Suppl 2:S144-51
Monheit GD, Prather CL. (2007) Juvéderm: a hyaluronic acid dermal filler. J Drugs Dermatol Nov;6(11):1091-5
Monstrey SJ, Pitaru S, Hamdi M, et al. A two-stage phase I trial of Evolence30 collagen for soft-tissue contour correction. Plast Reconstr Surg 120(1):303-11 (2007 Jul)
Narins RS, Brandt F, Leyden, Lorenc ZP, Rubin M, Smith S. (2003) A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg Jun;29(6):588-95
Narins RS, Brandt F, Leyden, Lorenc ZP, Rubin M, Smith S. (2003) A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg Jun;29(6):588-95.
ordan DR. (2005) Delayed inflammatory reaction to hyaluronic acid (Restylane). Ophthal Plast Reconstr Surg Sep;21(5):401-2.
PMA of Juvéderm (PMA P050047 – 02/06/2006) / Baumann LS, Shamban AT, Lupo MP et al. (2007) Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Dec;33 Suppl 2:S128-35.
PMA of Restylane Injectable Gel (PMA P020023 – 14/06/2003) / Narins RS, Brandt F, Leyden J et al. (2003) A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg Jun;29(6):588-95.
Preclinical Summary of Restylane P020023, FDA; http://www.fda.gov/ohrms/dockets/AC/03/briefing/4004b1_07_Preclinical%20Sum mary-Redacted.pdf
Raulin C, Greve B, Hartschuh W, Soegding K. (2000) Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Dermatitis 43:178-9.
Requena C, Izquierdo MJ, Navarro M, Martinez A, Vilata JJ, Botella R, Amorrortu J, Sabater V, Aliaga A, Requena L. (2001) Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol Jun23(3):197-202.
Rohrich RJ, Ghavami A, Crosby MA (2007) The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations. Plast Reconstr Surg Nov;120(6 Suppl):41S-54S
Rohrich RJ, Pessa JE, RistowB. The youthful cheek and the deep medial fat compartment. Plast Reconstr Surg. 2008 Jun; 121(6) : 2107-12
Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007 Jun;119(7):2219-27; discussion 2228-31
Rzany B, de Maio M. (2006) Injectable Fillers in Aesthetic Medicine. Springer- Verlag Berlin and Heidelberg GmbH & Co. K.
Sidwell RU, Dhillon AP, Butler PE, Rustin MH. (2004) Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin Exp Dermatol Nov;29(6):630-2.
Smith KC. (2007) Practical use of Juvéderm: early experience. Plast Reconstr Surg Nov;120(6 Suppl):67S-73S.
Soparker CN, patrinely JR. (2005) Managing inflammatory reaction to Restylane. Ophthal Plast Reconstr Surg Mar,21(2):151-3
Tosti A, De Padova MP (2007) Atlas of Mesotherapy in skin rejuvenation.
Vargas-Machuca I, Gonzalez-Guerra E, Angulo J, del Carmen Farina M, Martin L, Requena L. (2006) Facial granulomas secondary to Dermalive microimplants: Report of a case with histopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials. Am J Dermatopathol Apr;20(2):173-7.
Zielke H, Wölber L, Weist L, Rzany B. (2008) Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg Mar;34(3):326-35; discussion 335. Epub 2007 Dec 20.

DISTRIBUSJON I VERDEN

Molderm® distribueres via og KUN av et eksklusivt distribusjonsnettverk for å sikre samme kvalitet og identitet, felles verdier og konsept, uansett hvor du befinner deg. Du har kun muligheten til å bestille dine Molderm®-produkter fra distributøren som er ansvarlig for området du befinner deg i. Klikk på “se distributørliste” nedenfor for å finne din distributør.

Interessert i å få eksklusive distribusjonsrettigheter for Molderm® i ditt land? Vennligst klikk på “bli distributør” for søknad og første kontakt.